Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030

Highlights ► Rotavirus vaccines may be more widely available to GAVI-eligible countries. ► Rotavirus vaccination is very cost-effective in all GAVI-eligible countries. ► Between 2011 and 2030 vaccination is projected to avert 2.46 million childhood deaths. ► Vaccination is projected to reduce childh...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2012-04, Vol.30, p.A7-A14
Main Authors: Atherly, Deborah E, Lewis, Kristen D.C, Tate, Jacqueline, Parashar, Umesh D, Rheingans, Richard D
Format: Article
Language:English
Subjects:
Allergy and Immunology
Child, Preschool
childhood
children
Cost-effectiveness
Costs and Cost Analysis
death
Developing Countries
Diarrhea - economics
Diarrhea - epidemiology
Diarrhea - mortality
Diarrhea - prevention & control
disability-adjusted life year
economic impact
gross domestic product
Health impact
Humans
Immunization Programs - economics
Infant
Infant, Newborn
Models, Statistical
mortality
Prevalence
Rotavirus
Rotavirus Infections - economics
Rotavirus Infections - epidemiology
Rotavirus Infections - mortality
Rotavirus Infections - prevention & control
Rotavirus vaccines
Rotavirus Vaccines - administration & dosage
Rotavirus Vaccines - economics
Rotavirus Vaccines - immunology
vaccination
vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Rotavirus vaccines may be more widely available to GAVI-eligible countries. ► Rotavirus vaccination is very cost-effective in all GAVI-eligible countries. ► Between 2011 and 2030 vaccination is projected to avert 2.46 million childhood deaths. ► Vaccination is projected to reduce childhood deaths by 180,000 annually. ► Policy-makers can use relevant economic and impact data to make resource allocation decisions.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2011.12.096